St. Louis, MO (Feb 16, 2021) – Life science venture capital firm RiverVest continues to expand its team with the addition of Pascal Krotee as senior associate in the San Diego office.

“RiverVest has an extraordinary track record of creating and investing in groundbreaking and successful technologies that change patients’ lives for the better,” said Krotee. “They have achieved these results by putting collaboration, innovation and transparency above all else.”

At RiverVest, Krotee is involved in the sourcing of deals and completion of due diligence on prospective investments. She is also instrumental in supporting the operational activities of RiverVest’s portfolio companies.

“In addition to her strong scientific expertise, Pascal brings a demonstrated ability to work effectively with academic founders and seed-stage companies,” said managing director Jay Schmelter. “We are thrilled by her addition as we continue to deepen RiverVest’s team.”

Prior to RiverVest, Krotee spent four years as an investment associate at Kairos Ventures, where she focused on both therapeutics and medical device investments. Krotee earned her Ph.D. in molecular biology at UCLA, where she studied the atomic structures of proteins associated with Alzheimer’s disease and type-II diabetes. She earned a B.S. in developmental and cell biology with a minor in business management from UC Irvine.

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Learn More